CIK 0001903784 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vogenx, Inc.
Sign in to watch- Ticker
- VOGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863697324
- Phone
- 9196595677
- Business address
- 3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC, 27609
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Wilkison William Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2026-10-02 | Toombs Kenneth John Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-10-02 | Pieraccini Peter Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-10-02 | Green James Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2026-10-02 | DELMAR STEVEN R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2026-10-02 | Boris Timothy Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-08-13 | Pieraccini Peter Director | Conversion | +42,735 | $11.70 | $500K | 42,735 |
| 2026-08-13 | Pieraccini Peter Director | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2026-08-13 | DELMAR STEVEN R Chief Financial Officer | Conversion | +4,273 | $11.70 | $50K | 704,273 |
| 2026-08-13 | DELMAR STEVEN R Chief Financial Officer | Conversion · Convertible Promissory Note | −0 | 0 |
Page 1 of 1 · 10 trades